Newsletter Archive

  1. 03.22.17 -- Evidence Synthesis: Reducing The Guesswork Of Clinical Trial Design
    3/22/2017
    03/22/17 Clinical Leader Newsletter
  2. 03.20.17 -- 3 Bad Ideas For FDA Pre-Sub Meetings
    3/20/2017
    03/20/17 Clinical Leader Newsletter
  3. 03.15.17 -- FDA Reports On 2016 Diversity Results
    3/15/2017
    03/15/17 Clinical Leader Newsletter
  4. 03.13.17 -- Finding The Right CRO For Rare Disease Trials
    3/13/2017
    03/13/17 Clinical Leader Newsletter
  5. 03.08.17 -- GSK Uses Apple ResearchKit In Rheumatoid Study
    3/8/2017
    03/08/17 Clinical Leader Newsletter
  6. 03.06.17 -- The Science Of M&A: Making The Most Of Your Financial Resources
    3/6/2017
    03/06/17 Clinical Leader Newsletter
  7. 03.01.17 -- How Many Team Members Does It Take To Determine The Study Status?
    3/1/2017
    03/01/17 Clinical Leader Newsletter
  8. 02.28.17 -- Continuous Processing In BioManufacturing
    2/28/2017
    02/28/17 Clinical Leader Newsletter
  9. 02.27.17 -- Paratek Successfully Tackles Patient Challenges In Phase 3 Trial
    2/27/2017
    02/27/17 Clinical Leader Newsletter
  10. 02.22.17 -- The Evolution Of Medical Imaging In Clinical Research
    2/22/2017
    02/22/17 Clinical Leader Newsletter